羽绒服饰

搜索文档
DeFi Development Corp. Announces June 2025 Business Update
Globenewswire· 2025-07-03 04:15
公司核心信息 - 公司为DeFi Development Corp.,是首家采用积累和复利Solana(“SOL”)的资金储备策略的美国上市公司 [1] - 公司是人工智能驱动的在线平台,连接商业房地产行业,为多户和商业地产专业人士提供数据和软件订阅及增值服务 [4] 公司动态 - 2025年7月2日发布2025年6月股东信和业务更新,可访问https://defidevcorp.com/investor查看全文 [1] - 2025年7月3日上午8点左右将在youtube.com/DeFiDevCorp上传CEO、CFO、COO & CIO和投资者关系主管参与的视频更新,管理层将介绍战略亮点并回答散户投资者和卖方分析师提前提交的问题 [2] 公司业务模式 - 采用资金储备政策,将资金储备的主要持仓分配给SOL,为投资者提供对SOL的直接经济敞口,同时积极参与Solana生态系统的发展 [3] - 除持有和质押SOL外,运营自己的验证器基础设施,从委托质押中获得质押奖励和费用 [3] - 涉足去中心化金融(DeFi)机会,继续探索支持Solana不断扩展的应用层并从中受益的创新方式 [3] - 数据和软件产品通常以软件即服务(“SaaS”)的订阅形式提供 [5] 公司服务对象 - 每年服务超100万网络用户,包括每年申请数十亿美元债务融资的多户和商业地产所有者及开发商、专业服务提供商、数千家多户和商业地产贷款机构 [5] - 服务的贷款机构包括超10%的美国银行、信用合作社、房地产投资信托(“REITs”)、债务基金、房利美和房地美多户贷款机构、联邦住房管理局多户贷款机构、商业抵押担保证券(“CMBS”)贷款机构、小企业管理局(“SBA”)贷款机构等 [5] 联系方式 - 投资者联系邮箱:ir@defidevcorp.com [6] - 媒体联系:Prosek Partners,邮箱pro-ddc@prosek.com [6]
Mercury Selected to Improve U.S. Defense Supply Chain Resilience for Priority Domestic Microelectronics Technology
Globenewswire· 2025-07-03 04:15
文章核心观点 水星系统公司获美国国防部工业基地分析与维持(IBAS)计划资助,将与商业伙伴合作开发下一代射频信号调理多芯片封装(MCP),以提升X波段有源电子扫描阵列(AESA)雷达性能并降低成本 [1][2] 公司概况 - 水星系统是一家为前沿提供关键任务处理的技术公司,其产品和解决方案应用于超300个项目,遍布35个国家,总部位于马萨诸塞州安多弗,全球有超20个地点 [4] 项目情况 - 公司获国防部IBAS计划资助,将与商业伙伴系统创新工程公司签订为期两年、价值850万美元的合同,开发并展示新解决方案,提升X波段AESA雷达性能和成本效益 [1][2] - 新的超紧凑型信号调理封装将利用公司在微波和混合信号技术方面的专业知识和创新,使集成组件的尺寸、重量和功率要求比现有硬件降低超80%,且更具可生产性、提高经济性并支持大批量任务 [2] 各方观点 - 公司信号技术高级副总裁肯·赫尔曼尼称,该奖项体现国防部对公司快速开发创新射频解决方案能力的信心,公司正在构建首个针对性能优化且可扩展的信号调理模块 [3] - 公司高级概念集团高级封装高级总监托尼·特里恩表示,该项目体现公司处理平台整合创新的能力,通过整合企业能力构建高性能解决方案,加速技术应用并支持客户任务 [3] - 美国海军水面作战中心克莱恩分部首席科学家约翰·斯科菲尔德称,该能力将在提升射频传感器性能和应对未来威胁方面发挥关键作用,支持作战人员进行更快、更可靠的威胁检测 [3]
Steve Sanghi to Continue as Microchip CEO and President on a Permanent Basis
Globenewswire· 2025-07-03 04:15
文章核心观点 Microchip Technology Incorporated宣布Steve Sanghi将永久担任公司首席执行官、总裁及董事会主席,董事会认为他能带领公司长期执行目标,他本人也期待继续服务公司实现目标 [1][2] 公司人事变动 - Steve Sanghi自2024年11月起临时担任公司首席执行官和总裁,现同意永久担任该职位,同时继续担任董事会主席 [1] - Steve Sanghi在2021年退休前曾担任Microchip首席执行官近30年 [1] 董事会看法 - 董事会很高兴Steve Sanghi同意永久担任首席执行官和总裁,自他临时履职以来采取果断行动制定并实施恢复计划,认为他是带领公司长期执行目标的最佳人选 [2] Steve Sanghi表态 - Steve Sanghi表示已领导Microchip超30年,期待长期继续服务公司,虽恢复计划部分已完成或基本实施,但实现长期运营模式等还需持续努力,感谢董事会信任 [2] 公司概况 - 公司是智能、互联和安全嵌入式控制解决方案的领先提供商,开发工具易用、产品组合全面,能帮助客户降低风险、成本和上市时间 [3] - 公司解决方案服务约109,000家客户,涵盖工业、汽车、消费、航空航天和国防、通信和计算市场 [3] - 公司总部位于亚利桑那州钱德勒,提供出色技术支持、可靠交付和质量 [3]
Black Hills Corp. Schedules 2025 Second-Quarter Earnings Release and Conference Call
Globenewswire· 2025-07-03 04:15
RAPID CITY, S.D., July 02, 2025 (GLOBE NEWSWIRE) -- Black Hills Corp. (NYSE: BKH) will announce its 2025 second-quarter earnings after the market closes Wednesday, July 30, 2025, and will host a live conference call and webcast at 11 a.m. EDT on Thursday, July 31, 2025, to discuss the company’s financial results. To participate by phone and ask a question during the live broadcast, participants can access the event directly at Black Hills Corp. Conference Call. Please allow at least five minutes to register ...
Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option
Globenewswire· 2025-07-03 04:15
FLORHAM PARK, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the closing of its previously announced underwritten public offering for gross proceeds of approximately $6.9 million prior to deducting underwriting commissions and offering expenses. The offering includes participation from healthcare dedicated funds an ...
Oragenics Completes Approximately $16.5 Million Offering
Globenewswire· 2025-07-03 04:15
Proceeds to drive development of ONP-002, the Company’s lead intranasal drug candidate for mild traumatic brain injurySARASOTA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering intranasal therapeutics for neurological disorders, today announced the successful closing of its previously announced public offering of Series H Convertible Preferred Stock and Warrants. The Company secured total gross proceeds of approximately $16.5 mi ...
FONAR Board of Directors Appoints Independent Director
Newsfile· 2025-07-03 04:10
FONAR Board of Directors Appoints Independent DirectorJuly 02, 2025 4:10 PM EDT | Source: Fonar CorporationMelville, New York--(Newsfile Corp. - July 2, 2025) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning, today announced that on July 2, 2025, its board of directors appointed Mr. Robert M. Carrino as an independent director of the Company's board of directors. This appointment fills a vacancy on the board left by Ms. Claudette J.V. Chan, who recently retired from her position ...
Compass Diversified Declares Second Quarter 2025 Distributions on Series A, B and C Preferred Shares
Globenewswire· 2025-07-03 04:10
WESTPORT, Conn., July 02, 2025 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today that its Board of Directors (the “Board”) has declared a quarterly cash distribution for each of its three preferred share series. This announcement underscores that in the wake of its ongoing investigation of Lugano, the Company’s diversified business model supports its continued ability to generate strong cash flow. The Board declared ...
Euroseas Ltd. Announces Annual Meeting of Shareholders
GlobeNewswire News Room· 2025-07-03 04:10
ATHENS, Greece, July 02, 2025 (GLOBE NEWSWIRE) -- Euroseas Ltd. (NASDAQ: ESEA), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today that its Board of Directors has called an annual meeting of the shareholders to be held on July 23, 2025, at 11:00 a.m. at the offices of Seward & Kissel LLP, located at 901 K Street NW, Suite 800, Washington, DC 20001. Shareholders of record at the close of business on June 25, 2025, are entitled ...
Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA® Pediatric Registry
Globenewswire· 2025-07-03 04:09
Acclarent AERA® Eustachian Tube Balloon Dilation System First Patient Enrolled in Acclarent AERA® Pediatric Registry PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first patient in the Acclarent AERA Pediatric Registry, a prospective, multi-center observational registry evaluating the real-world use of the AERA Eustachian Tube Balloon Dilation System in childre ...